Qualigen Therapeutics Inc... (QLGN)
NASDAQ: QLGN
· Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT
Qualigen Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.65M | -1.06M | -1.79M | -1.48M | -2.03M | -2.47M | -2.39M | -3.51M | -4.11M | -8.53M | -4.06M | -4.13M | -4.32M | -6.06M | -2.86M | -5.31M | -3.67M |
Depreciation & Amortization | 73.61K | n/a | n/a | n/a | n/a | 4.5K | -239.09K | 122.79K | 116.3K | 109.99K | 89.55K | 91.82K | 84.24K | 89.22K | 85.61K | 81.82K | 81.63K |
Stock-Based Compensation | 269.00 | 9.11K | 27.21K | 33.09K | 58.65K | 69.69K | 122.7K | 653.92K | 252.23K | 1.38M | 1.41M | 1.42M | 1.27M | 1.43M | 1.31M | 1.29M | 1.26M |
Other Working Capital | 973.32K | -1.1M | -485.34K | 222.78K | 1.02M | -295.07K | 88.86K | -533.45K | 293.81K | 245.33K | 73.71K | -1.27M | -224.35K | -247 | 80.64K | -798.69K | 2.39M |
Other Non-Cash Items | 46.91K | -261.83K | 667.78K | -306.4K | 1.07M | -4.21M | 3.45M | 254.18K | 614.82K | 4.28M | -129.81K | -22.45K | -767.3K | 1.33M | -1.85M | -2.17M | 101.75K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 572.47K | -150.37K | -410.66K | -165.17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.08M |
Change in Working Capital | 935.99K | -960.98K | -700.79K | 275.34K | 602.85K | 356.09K | 141.38K | -40.86K | 654.98K | 521.11K | -495.38K | -1.31M | -145.94K | 301.92K | 277.31K | -596.8K | 2.23M |
Operating Cash Flow | -1.59M | -2.27M | -1.8M | -1.47M | -783.59K | -5.67M | 929.74K | -2.93M | -2.63M | -2.24M | -3.18M | -3.95M | -3.88M | -2.91M | -3.03M | -6.7M | -2.08M |
Capital Expenditures | n/a | n/a | n/a | 2.00 | n/a | n/a | 246.42K | -48.41K | -198.01K | -244.37K | -11.26K | -13.86K | -49.63K | -17.01K | -9.66K | -45.69K | -69K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -135.35K | n/a | 135.35K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.82M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -305K | -1.01M | -1.25M | 350K | n/a | 235.4K | 3.98M | n/a | -198.01K | 135.35K | -11.26K | n/a | n/a | -8.82M | n/a | n/a | -6.74K |
Investing Cash Flow | -305K | -1.01M | -1.25M | 350K | n/a | 235.4K | 4.23M | -48.41K | -198.01K | -244.37K | -11.26K | 121.5K | -49.63K | -17.01K | -9.66K | -45.69K | -69K |
Debt Repayment | n/a | -499.02K | n/a | 1M | 475K | n/a | -440K | n/a | n/a | 2.9M | n/a | n/a | n/a | n/a | n/a | -15.61K | 1.27M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | -87.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 750K | 4.56M | 87.6K | 150K | n/a | -110K | n/a | n/a | n/a | -505 | 3.31K | n/a | 3.86K | -671.2K | 129.43K | 49.74K | -1.15M |
Financial Cash Flow | 750K | 4.06M | 3.32M | 1.15M | 475K | -110K | -440K | n/a | n/a | 2.9M | 3.31K | n/a | 3.86K | 8.15M | 129.43K | 34.13K | 121.45K |
Net Cash Flow | -1.14M | 786.46K | 269.47K | 25.47K | 141.41K | -1.67M | 726.76K | -3.02M | -2.67M | 416.36K | -3.13M | -3.86M | -3.93M | 5.22M | -2.91M | -6.72M | -2.03M |
Free Cash Flow | -1.59M | -2.27M | -1.8M | -1.47M | -783.59K | -5.67M | 1.18M | -2.98M | -2.83M | -2.48M | -3.19M | -3.96M | -3.93M | -2.93M | -3.04M | -6.75M | -2.15M |